Synergy between an IGF-1R antibody and Raf/MEK/ERK and PI3K/Akt/mTOR pathway inhibitors in suppressing IGF-1R-mediated growth in hematopoietic cells.

Source:http://linkedlifedata.com/resource/pubmed/id/16642049

Download in:

View as

General Info

PMID
16642049